13F
中

DNTH DIANTHUS THERAPEUTICS INC

2026Q1 · CUSIP 252828108 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
240
Δ holders QoQ
+74
Breadth percentile
Top 2%
Whale holders
117
Δ whales
+35
Inst. holding value
$5.2B
New positions
97
Closed positions
23
Price momentum (1Q)
+69.9%
Put / Call
5/5

Breadth history (34 quarters)

2023Q4: Δ+9 · h=40 2024Q1: Δ+37 · h=77 2024Q2: Δ-2 · h=75 2024Q3: Δ+17 · h=92 2024Q4: Δ+5 · h=97 2025Q1: Δ+3 · h=100 2025Q2: Δ+4 · h=104 2025Q3: Δ+38 · h=142 2025Q4: Δ+24 · h=166 2026Q1: Δ+74 · h=240 2023Q4: holders=40 2024Q1: holders=77 2024Q2: holders=75 2024Q3: holders=92 2024Q4: holders=97 2025Q1: holders=100 2025Q2: holders=104 2025Q3: holders=142 2025Q4: holders=166 2026Q1: holders=240 -74 -37 +0 +37 +74 36144252 23Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 4 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 2% — —
2025Q3 Top 7% +20.2% +114.6%
2024Q3 Top 20% +0.3% -22.2%
2024Q1 Top 6% +11.8% -8.9%

Options Sentiment

Put holders
5
QoQ: +3
Call holders
5
QoQ: +4

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-4.23
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-03-31: EPS -0.54 2024-06-30: EPS -0.51 2024-09-30: EPS -0.74 2024-12-31: EPS -0.76 2025-03-31: EPS -0.82 2025-06-30: EPS -0.88 2025-09-30: EPS -0.97 2025-12-31: EPS -1.53 2026-03-31: EPS -0.85 -1.68 -0.84 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)